CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

NCT05672147 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

City of Hope Medical Center

Collaborators